Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing
Reexamination Certificate
2006-02-14
2006-02-14
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
C424S400000, C424S520000, C424S522000, C514S104000
Reexamination Certificate
active
06998109
ABSTRACT:
The present formulation is an analgesic, anesthetic and anti-pruritic formulation with from about 10.0 wt % to about 75.0 wt % Emu oil; from about 10.0 wt % to about 33.0 wt % benzyl alcohol; from about 0.25 wt % to about 5.0 wt % allantoin; from about 0.1 wt % to about 5.0 wt % methylparaben; from about 0.1 wt % to about 2.0 wt % propylparaben; and from about 0.5 wt % to about 4.0 wt % of lidocaine, wherein the formulation is adapted to inhibit microbial activity fromEscherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Candida albicans, Streptococcus agalactiaeor combinations thereof, and wherein the lidocaine relieves pain on the epidermis of humans and animals of skin irritations, wounds, or burns.
REFERENCES:
patent: 5698227 (1997-12-01), Rivlin
patent: 5849334 (1998-12-01), Rivlin
patent: 6444234 (2002-09-01), Kirby
patent: 6528040 (2003-03-01), Pearson et al.
patent: 6579543 (2003-06-01), McClung
patent: 2004/0247707 (2004-12-01), Le Roy et al.
Barr Teresa Leigh
Pearson Maurine
Buskop Wendy
Buskop Law Group P.C.
Pearson Research & Development Limited
Pryor Alton
LandOfFree
Emu-based formulations with lidocaine for wound treatment by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Emu-based formulations with lidocaine for wound treatment by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Emu-based formulations with lidocaine for wound treatment by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693437